Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Oral Tacrolimus for Megacolon in Patients with Severe Ulcerative Colitis
Ken NarabayashiTakuya InoueTaisuke SakanakaMunetaka IguchiKaori FujiwaraNaoki YorifujiKazuki KakimotoSadaharu NoudaToshihiko OkadaKumi IshidaYosuke AbeDaisuke MasudaToshihisa TakeuchiShinya FukunishiEiji UmegakiKazuhide Higuchi
著者情報
ジャーナル オープンアクセス

2014 年 53 巻 16 号 p. 1755-1758

詳細
抄録
Toxic megacolon is an infrequent but life-threatening complication that occurs most commonly in patients with severe ulcerative colitis. Intravenous steroids are often recommended for patients with toxic megacolon secondary to ulcerative colitis. However, steroid dependency may mask the presence of intra-abdominal sepsis and is associated with refractoriness, during which cytomegalovirus reactivation may occur. In this report, we present two rare cases of megacolon accompanying pancolonic severe ulcerative colitis that were successfully treated with oral tacrolimus, including one steroid-naïve patient. In cases of ulcerative colitis with megacolon, treatment with oral tacrolimus is recommended, thereby avoiding steroid dependency and improving the long-term prognosis.
著者関連情報
© 2014 by The Japanese Society of Internal Medicine
前の記事 次の記事
feedback
Top